Physicians in clinic

Clinical Cardiovascular Research at the Medical College of Georgia

Cardiovascular disease is the leading cause of morbidity and mortality in the United States.  Investigating the mechanisms of various types of cardiovascular disease is essential to the development of new treatments that save lives.  Cardiovascular Research at the Medical College of Georgia is focused on achieving a greater understanding of normal structure and function as well as the development of disease processes. 

Current funded clinical research:

Principle Investigator Project Title Direct Sponsor Project Begin Project End
Berman, Adam Mapping of the Coronary Sinus During Implant of a Biventricular Implantable Cardiodefibrillator Utilizing the NAVX Mapping System (BiV NAVX) St. Jude Medical 17-Jan-07 31-Mar-09
Berman, Adam Lead and Delivery Tools (LAND-IT) Registry St. Jude Medical 1-Dec-06 31-May-07
Berman, Adam Correlation of Pace-Mapping of Ventricular Tachycardia and Complex Fractionated Electrogram Distribution During Ablation of Ischemic Ventricular Tachycardia Using NAVX Mapping (VT CFE) St. Jude Medical 17-Aug-07 16-Aug-08
Gladysheva, Inna Regulation of structure and activity of the cardiomyocyte specific pro-ANP convertase, corin by mast cell proteases American Heart Association 1-Jul-08 30-Jun-12
Kapoor, Deepak PROTECT II-A prospective, multi-center, randomized controlled trial of the IMPELLA RECOVER LP 2.5 System versus Intra Aortic Balloon Pump (IABP) in Patients Undergoing Non Emergent High Risk PCI Abiomed, Inc. 13-Oct-08 31-Aug-10
Robinson, Vincent J. A Prospective, Randomised, Double-Blind, Double-Dummy, Parallel Group, Multicenter, Event Driven, Non-Inferiority Study Comparing the Efficacy and Safety of Once-Daily Oral Rivarobaxban (BAY 59-7939) With Adjusted-Dose Oral Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Subjects with Non-Valvular Atrial Fibrillation Johnson & Johnson Pharmaceutical R&D 31-Oct-07 30-Jun-13
Robinson, Vincent J. "Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) Comparing the Efficacy and Safety of Two Blinded Doses Dabigatran Etexilate with Open Label Warfarin for the Prevention of Stroke and Systemic Embolic Events in Patients with Non-Vulvular Atrial Fibrillation. A Prospective, Randomised, Open Label, Active Controlled, Multicenter, Parallel-Group Non-Inferiority Trial (RE-LY STUDY)" Boehringer Ingelheim 21-Feb-06 20-Aug-09
Robinson, Vincent J. D-Dimer Assay, a Possible Tool in the Evaluation of Atrial Thrombosis - APPLICANT: UZOMA N. IBEBUOGU American Medical Association Foundation 17-Apr-07 16-Oct-08
Sazonova, Irina Molecular Chimerization of Plasmin: Comparative Effects on Thrombolysis of Embolic Cerebral Ischemia American Heart Association 1-Jan-08 31-Dec-11
Sharma, Gyanendra Sanofi-Aventis, A Multi-Center, Phase 3b, Stratified, Randomized, Open-Label Clinical Trial to Evaluate the Efficacy of Intensive Apidra/Lantus Therapy Versus Sliding Scale Insulin on Infarct Size in Hyperglycemic Subjects with Anterior STEMI (ST evaluation myocardial infarction) Undergoing PCI (percutaneous coronanry intervention) Sanofi-Aventis 28-Mar-08 1-Dec-09
Thornton, John HOME AUTOMATIC EXTERNAL DEFIBRILLATOR TRIAL -H.A.T. Seattle Institute for Cardiac Research 1-Feb-03 31-Aug-09

Cover of Cardiovascular News of Excellence Issue 5

Clinical research featured in Cardiovascular News of Excellence

Revised May 11, 2009.   Please send comments, suggestions or questions about this page to Web pages managed by Michael Konomos, mkonomos@mcg.edu .